These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31000433)

  • 1. In-Vivo Vascular Healing Following Bifurcation Interventions with the Absorb Bioresorbable Vascular Scaffold.
    Bennett J; Verbeken E; Vanhaverbeke M; McCutcheon K; Adriaenssens T; Vanden Driessche N; Sinnaeve P; Desmet W; Dubois C
    Cardiovasc Revasc Med; 2020 Jan; 21(1):70-77. PubMed ID: 31000433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorb Bioresorbable Vascular Scaffold in Complex Coronary Bifurcation Interventions: Insights From an In Vivo Multimodality Imaging Study.
    Bennett J; Vanhaverbeke M; Vanden Driessche N; Adriaenssens T; Hiltrop N; Desmet W; Sinnaeve P; Dubois C
    Circ Cardiovasc Interv; 2016 Aug; 9(8):. PubMed ID: 27512090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V; Colombo A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug-eluting resorbable magnesium vascular scaffold in complex coronary bifurcations: insights from an in vivo multimodality imaging study.
    Bennett J; Vanhaverbeke M; Vanden Driessche N; Hiltrop N; Adriaenssens T; Desmet W; Sinnaeve P; Dubois C
    EuroIntervention; 2018 Apr; 13(17):2036-2046. PubMed ID: 28741575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
    Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process.
    Lee R; Foin N; Ng J; Allen J; Soh N; Ang I; Shim W; Torii R; Wong P
    EuroIntervention; 2016 Aug; 12(5):e605-14. PubMed ID: 27497360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study.
    Lhermusier T; Ohayon P; Boudou N; Bouisset F; Campelo-Parada F; Roncalli J; Elbaz M; Carrié D
    Trials; 2019 Apr; 20(1):210. PubMed ID: 30975219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-year follow-up optical coherence tomography of a "hybrid" neocarina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent.
    Naganuma T; Panoulas VF; Latib A; Kawamoto H; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2015 May; 8(6):e101-e103. PubMed ID: 25912406
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.
    Gogas BD; Radu M; Onuma Y; Perkins L; Powers JC; Gomez-Lara J; Farooq V; Garcia-Garcia HM; Diletti R; Rapoza R; Virmani R; Serruys PW
    Int J Cardiovasc Imaging; 2012 Mar; 28(3):499-511. PubMed ID: 21503708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
    Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
    Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.
    Abdelaziz HK; Abuomara HZ; Ali MH; Eichhofer J; Patel B; Saad M
    Coron Artery Dis; 2019 Jun; 30(4):263-269. PubMed ID: 30883433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.
    Gasior P; Cheng Y; Xia J; Conditt GB; McGregor JC; Virmani R; Granada JF; Kaluza GL
    Cardiol J; 2020; 27(2):115-125. PubMed ID: 30155861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
    Yamaji K; Ueki Y; Souteyrand G; Daemen J; Wiebe J; Nef H; Adriaenssens T; Loh JP; Lattuca B; Wykrzykowska JJ; Gomez-Lara J; Timmers L; Motreff P; Hoppmann P; Abdel-Wahab M; Byrne RA; Meincke F; Boeder N; Honton B; O'Sullivan CJ; Ielasi A; Delarche N; Christ G; Lee JKT; Lee M; Amabile N; Karagiannis A; Windecker S; Räber L
    J Am Coll Cardiol; 2017 Nov; 70(19):2330-2344. PubMed ID: 29096803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography.
    Kraak RP; Kajita AH; Garcia-Garcia HM; Henriques JPS; Piek JJ; Arkenbout EK; van der Schaaf RJ; Tijssen JGP; de Winter RJ; Wykrzykowska JJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):E106-E114. PubMed ID: 29332307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.
    Gomez-Lara J; Radu M; Brugaletta S; Farooq V; Diletti R; Onuma Y; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Sep; 4(9):992-1001. PubMed ID: 21939939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.